| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Alejandro A. Rabinstein | Q86070388 |
| Jennifer E. Fugate | Q110863403 | ||
| P2860 | cites work | Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma | Q24669842 |
| Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly | Q28273131 | ||
| Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage | Q28285783 | ||
| Determinants of recovery from severe posterior reversible encephalopathy syndrome | Q28483772 | ||
| Hypertensive posterior reversible encephalopathy syndrome causing posterior fossa edema and hydrocephalus | Q30677631 | ||
| Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features | Q33324816 | ||
| Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura | Q33385191 | ||
| Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus | Q33407827 | ||
| Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders | Q33411707 | ||
| Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases | Q33488963 | ||
| Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature | Q33509042 | ||
| Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings | Q33570046 | ||
| The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients | Q33614057 | ||
| Monitoring cerebral blood flow pressure autoregulation in pediatric patients during cardiac surgery | Q33876269 | ||
| Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. | Q33916849 | ||
| Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome | Q33942730 | ||
| 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 | ||
| Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome | Q80854146 | ||
| Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus | Q83172960 | ||
| Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging | Q83223992 | ||
| Reversible cerebral vasoconstriction syndromes: analysis of 139 cases | Q83830907 | ||
| Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns | Q87328540 | ||
| Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome | Q37643506 | ||
| Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment | Q37921972 | ||
| Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. | Q37957052 | ||
| The astrocytic contribution to neurovascular coupling--still more questions than answers? | Q38082643 | ||
| Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases | Q38084126 | ||
| Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation | Q38086498 | ||
| Sympathetic regulation of cerebral blood flow in humans: a review. | Q38101547 | ||
| Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature | Q38237697 | ||
| Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome | Q38359014 | ||
| Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)? | Q38448661 | ||
| Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome | Q38448773 | ||
| Neurocognitive functioning following preeclampsia and eclampsia: a long-term follow-up study | Q39256512 | ||
| Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression | Q42419747 | ||
| Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? | Q42449813 | ||
| Involvement of the cervical cord and medulla in posterior reversible encephalopathy syndrome | Q42738989 | ||
| Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy. | Q42864216 | ||
| Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases | Q44049678 | ||
| Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome? | Q44294895 | ||
| Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. | Q44489098 | ||
| Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features | Q45816127 | ||
| Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. | Q46040353 | ||
| Posterior reversible encephalopathy syndrome in children: radiological and clinical findings - a retrospective analysis of a German tertiary care center | Q46140883 | ||
| Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome | Q46435601 | ||
| Blood pressure fluctuations in posterior reversible encephalopathy syndrome | Q46522888 | ||
| Posterior reversible encephalopathy syndrome: incidence and associated factors in a pediatric critical care population | Q46842141 | ||
| Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings | Q46989268 | ||
| Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management | Q47916708 | ||
| Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia | Q48169612 | ||
| Posterior reversible encephalopathy syndrome: long-term follow-up | Q48392391 | ||
| Variable presentations of postpartum angiopathy | Q48725266 | ||
| Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience | Q48735985 | ||
| Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation | Q48849293 | ||
| Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images | Q48894403 | ||
| CT perfusion imaging in the management of posterior reversible encephalopathy | Q48901300 | ||
| The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. | Q49109469 | ||
| Neurologic problems after pediatric liver transplantation and combined liver and bowel transplantations: a single tertiary centre experience | Q50268400 | ||
| Posterior reversible encephalopathy syndrome with spinal cord involvement. | Q51104469 | ||
| Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. | Q51539492 | ||
| Posterior reversible encephalopathy syndrome in childhood cancer. | Q51843058 | ||
| Hypertension-induced reversible posterior leukoencephalopathy syndrome causing obstructive hydrocephalus. | Q51894198 | ||
| Could increased vascular endothelial growth factor induced by interleukin 17 be the cause of posterior reversible encephalopathy syndrome in systemic lupus erythematosus? | Q53381970 | ||
| Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. | Q53447006 | ||
| Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. | Q53468648 | ||
| Posterior reversible encephalopathy syndrome: the endothelial hypotheses. | Q55057745 | ||
| Spinal cord involvement during hypertensive encephalopathy: clinical and radiological findings | Q60315996 | ||
| Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock | Q71843284 | ||
| Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging | Q73235211 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | posterior reversible encephalopathy syndrome | Q7234232 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 914-25 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions | |
| P478 | volume | 14 |
| Q64272678 | A Case of Posterior Reversible Encephalopathy Syndrome with Similar Symptoms as Transient Global Amnesia |
| Q42290736 | A Horned Viper Bite Victim with PRES. |
| Q64044492 | A case of posterior reversible encephalopathy syndrome associated with sepsis |
| Q50212344 | A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia |
| Q57807710 | Acute hemiparesis and status epilepticus following endoscopic esophageal balloon dilation: is it really a stroke? |
| Q58759199 | Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: Two case reports and a literature review |
| Q90706877 | Acute intermittent porphyria: A case report |
| Q42375441 | An atypical subacute presentation of posterior reversible encephalopathy syndrome |
| Q39127820 | Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger? |
| Q90272837 | Association Between Risk of Obstructive Sleep Apnea and Cerebrovascular Reactivity in Stroke Patients |
| Q55223788 | Association between Posterior Reversible Encephalopathy Syndrome and Mycoplasma pneumoniae infection. |
| Q92071064 | Blood-Brain Barrier Disruption as a Potential Target for Therapy in Posterior Reversible Encephalopathy Syndrome: Evidence From Multimodal MRI in Rats |
| Q92616204 | Brainstem Posterior Reversible Encephalopathy Syndrome |
| Q26750726 | Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review |
| Q92120535 | Cardiovascular and Neurologic Complications in Kidney Transplant Recipients: A Focused Appraisal of Symptoms |
| Q55004847 | Central-Variant Posterior Reversible Encephalopathy Syndrome with Albuminocytologic Dissociation. |
| Q48157949 | Cerebral lupus presented with late postpartum eclampsia and atypical reversible leucoencephalopathy. |
| Q97520928 | Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome |
| Q92639307 | Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis |
| Q98772117 | Challenges of Diagnosing Pediatric Posterior Reversible Encephalopathy Syndrome in Resource Poor Settings: A Narrative Review |
| Q91979943 | Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports |
| Q89288067 | Clinical Correlates of Periodic Discharges and Nonconvulsive Seizures in Posterior Reversible Encephalopathy Syndrome (PRES) |
| Q38624897 | Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome |
| Q91711338 | Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size |
| Q33715298 | Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome |
| Q48346904 | Color vision abnormality as the sole manifestation of posterior reversible encephalopathy due to post-partum HELLP syndrome |
| Q97905466 | Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria |
| Q48036196 | Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome |
| Q47551469 | Dengue-Associated Posterior Reversible Encephalopathy Syndrome, Vietnam |
| Q47576241 | Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia |
| Q39213448 | Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study |
| Q55492733 | Heat Stroke with Status Epilepticus Secondary to Posterior Reversible Encephalopathy Syndrome (PRES). |
| Q48188736 | Hypertensive encephalopathy mimicking cerebral vasculitis with pontine oedema, cerebellar white matter lesions and multiple cerebral infarctions |
| Q38910121 | Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome |
| Q37715160 | Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association |
| Q47102790 | Isolated pons involvement in Posterior Reversible Encephalopathy Syndrome: Case report and review of the literature |
| Q55317062 | MR imaging findings in some rare neurological complications of paediatric cancer. |
| Q33775053 | Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain |
| Q38746169 | Neurologic Complications of Commonly Used Drugs in the Hospital Setting |
| Q45072782 | Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact |
| Q38731142 | Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease |
| Q39004668 | Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications |
| Q49795334 | Neurological complications of solid organ transplantation |
| Q39031190 | Neurological sequelae of cancer immunotherapies and targeted therapies |
| Q51747748 | New Developments in Hypertensive Encephalopathy. |
| Q89019430 | Nocturnal Hypertension in Multiple System Atrophy May Cause Posterior Reversible Encephalopathy Syndrome |
| Q36437330 | Ondansetron-related hemorrhagic posterior reversible encephalopathy syndrome (PRES) following gastric bypass. |
| Q91939371 | Ophthalmic Manifestations of Posterior Reversible Encephalopathy Syndrome |
| Q47606304 | Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES). |
| Q50083962 | PRES: Review of Histological Features |
| Q91209146 | Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction |
| Q90206356 | Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome |
| Q96953480 | Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging |
| Q42735734 | Posterior Reversible Encephalopathy Syndrome Complicating Traumatic Pancreatitis: A Pediatric Case Report |
| Q92061216 | Posterior Reversible Encephalopathy Syndrome Due to Acute Water Intoxication in a Patient with Schizophrenia |
| Q39674013 | Posterior Reversible Encephalopathy Syndrome During Combined Modality Therapy for Head and Neck Squamous Cell Carcinoma. |
| Q48204872 | Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer |
| Q92688610 | Posterior Reversible Encephalopathy Syndrome Secondary to Hypertensive Encephalopathy Brought on by a MAO Inhibitor: A Case Report |
| Q57816848 | Posterior Reversible Encephalopathy Syndrome With Isolated Involving Infratentorial Structures |
| Q48282612 | Posterior Reversible Encephalopathy Syndrome With Spinal Cord Involvement in Children. |
| Q47923729 | Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma |
| Q88020326 | Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer |
| Q57465246 | Posterior Reversible Encephalopathy Syndrome and Guillain-Barré Syndrome after Head Injury: Case Report |
| Q93162422 | Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome after Rapid Blood Transfusion |
| Q89964987 | Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations |
| Q89940201 | Posterior Reversible Encephalopathy Syndrome and Septic Encephalopathy: Neuroimaging, Inflammation and Neurodegeneration Findings |
| Q60926816 | Posterior Reversible Encephalopathy Syndrome due to Hypomagnesemia: A Case Report and Literature Review |
| Q89964963 | Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports |
| Q42094466 | Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease on Infliximab |
| Q64943024 | Posterior Reversible Encephalopathy Syndrome in a Patient With Multiple System Atrophy. |
| Q40833981 | Posterior Reversible Encephalopathy Syndrome with Extensive Deep White Matter Lesions Including the Temporal Pole |
| Q47096072 | Posterior Reversible Leukoencephalopathy Syndrome (PRES) in Intensive Care Unit - Case series |
| Q38806470 | Posterior circulation cerebrovascular syndromes: diagnosis and management |
| Q53352069 | Posterior reversible encephalopathy in an adult patient with poststreptococcal glomerulonephritis. |
| Q59528263 | Posterior reversible encephalopathy syndrome |
| Q48275545 | Posterior reversible encephalopathy syndrome (PRES) after bariatric surgery--a potential consequence associated with rapid withdrawal of antihypertensive medications. |
| Q55174130 | Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer. |
| Q37710464 | Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report |
| Q50100508 | Posterior reversible encephalopathy syndrome (PRES) due to neuroblastoma in a child presenting with acute hydrocephalus |
| Q48001929 | Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature |
| Q31026391 | Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature. |
| Q47114919 | Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report |
| Q55398166 | Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review. |
| Q58613692 | Posterior reversible encephalopathy syndrome complicated with subarachnoid hemorrhage in an eclamptic pregnant patient: case report |
| Q45281928 | Posterior reversible encephalopathy syndrome complicating diabetic ketoacidosis; an important treatable complication |
| Q48283544 | Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura |
| Q60921159 | Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report |
| Q37586277 | Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common theme |
| Q50055948 | Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor? |
| Q33438960 | Posterior reversible encephalopathy syndrome in pregnancy: a retrospective series of 36 patients from mainland China |
| Q47573159 | Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review. |
| Q39314217 | Posterior reversible encephalopathy syndrome presenting in the anterior circulation with malignant intracranial hypertension requiring surgical decompression: a case report and literature review |
| Q98893409 | Posterior reversible encephalopathy syndrome with Lilliputian hallucinations secondary to Takayasu's arteritis |
| Q42291179 | Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab |
| Q92812765 | Posterior reversible encephalopathy syndrome with essential thrombocythemia: A case report |
| Q59136870 | Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review |
| Q64084196 | Posterior reversible encephalopathy syndrome with isolated infratentorial involvement: A case report |
| Q47866478 | Posterior reversible encephalopathy syndrome with spinal cord involvement (PRES-SCI) as a rare complication of severe diabetic ketoacidosis: a case report and review of the literature. |
| Q89966538 | Posterior reversible encephalopathy syndrome with spinal cord involvement as the first presentation of lupus nephritis |
| Q88800233 | Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report |
| Q92980345 | Predictive ability of admission neutrophil to lymphocyte ratio on short-term outcome in patients with spontaneous cerebellar hemorrhage |
| Q50042764 | Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke |
| Q90023184 | Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases |
| Q38881017 | Prognosis of cerebral lipiodol embolism caused by transarterial chemoembolization |
| Q89639263 | Recurrent HIV-associated posterior reversible encephalopathy syndrome |
| Q93098389 | Recurring posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis |
| Q38789469 | Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache |
| Q49876032 | Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone |
| Q47365128 | Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome associated with intracranial hypotension |
| Q55408109 | Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis. |
| Q92126639 | Simultanagnosia as a cause of visual disturbance following Posterior Reversible Encephalopathy Syndrome (PRES): A case report |
| Q40044399 | Sorafenib-induced reversible posterior leukoencephalopathy in patients with renal cell carcinoma: A report of two cases |
| Q40419945 | Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome |
| Q36201378 | Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: a case report |
| Q87871444 | Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension |
| Q100728537 | Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab |
| Q44540956 | The Clinical Outcome of Posterior Reversible Encephalopathy Syndrome. |
| Q41987697 | The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015. |
| Q38789242 | The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers |
| Q86488068 | The diagnosis of posterior reversible encephalopathy syndrome |
| Q95449040 | The diagnosis of posterior reversible encephalopathy syndrome |
| Q52147935 | The diagnosis of posterior reversible encephalopathy syndrome--Authors' reply. |
| Q52147936 | The diagnosis of posterior reversible encephalopathy syndrome. |
| Q49375853 | Thrombotic microangiopathy following haematopoietic stem cell transplant |
| Q43132801 | Transient Global Amnesia with Reversible White Matter Lesions: A Variant of Posterior Reversible Encephalopathy Syndrome? |
| Q37609064 | Uncoupling between cerebral perfusion and oxygenation during incremental exercise in an athlete with postconcussion syndrome: a case report |
| Q42377761 | Unusual Case of Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis: A Case Report and Review of the Literature |
| Q41317406 | Uremic encephalopathy with isolated brainstem involvement revealed by magnetic resonance image: a case report. |
| Q90382497 | Utilization of Ocular Ultrasound in the Evaluation of Posterior Reversible Encephalopathy Syndrome: A Case Report |
| Q91232763 | Variant Type of Posterior Reversible Encephalopathy Syndrome Associated with Deep Brain Hemorrhage: Case Report and Review of the Literature |
| Q42618099 | Why you may need a neurologist to see a comatose patient in the ICU. |
| Q89838451 | [Clinical and imaging course of posterior reversible encephalopathy syndrome in a patient with endocarditis and arterial hypertension] |
| Q53087573 | [Posterior reversible encephalopathy syndrome]. |
| Q95511671 | [Research advances of posterior reversible encephalopathy syndrome in children] |
| Q58608667 | [Toxic changes of the central nervous system] |
Search more.